Additionally, miR-20a could enhance DDP resistance of OVCAR3 ovarian cancer cells by altering the expression of EMT markers (E-cadherin, N-cadherin, and vimentin) (Liu et al., 2017). This evidence concerns the gene CDH1 and ovarian cancer.